The Trump administration has ordered a halt to the distribution of HIV medications bought with U.S. aid, in what is part of a broader freeze on foreign assistance. The delay affects the $7.5 billion PEPFAR program and has left local clinics without critical medications for HIV-positive patients. Health experts express alarm, warning that such actions could lead to hundreds of thousands of deaths in South Africa alone. Advocacy groups are in disarray as their operational commitments are jeopardized, showcasing the immense impact of these policy changes on global health efforts.
The partners we collaborate with are in shock, and they do not know what to do because their lifesaving mission and commitment has been breached, Asia Russell, executive director of the advocacy group Health Gap, told the Times.
This is another domino in the devastating impact of the harmful freeze to programs, leaving lives hanging in the balance, he told the Times.
Collection
[
|
...
]